Exane Derivatives G1 Therapeutics, Inc. Transaction History

Exane Derivatives

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$10.16 - $16.17 $92,323 - $146,936	-9,087 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$13.16 - $22.47 $30,873 - $52,714	2,346 Added 34.8%	9,087 $121,000
Q2 2021 Jul 28, 2021	BUY	$19.57 - $26.32 $12,348 - $16,607	631 Added 10.33%	6,741 $147,000
Q1 2021 Apr 30, 2021	SELL	$17.58 - $32.59 $703 - $1,303	-40 Reduced 0.65%	6,110 $147,000
Q4 2020 Jan 27, 2021	BUY	$10.99 - $20.4 $3,516 - $6,528	320 Added 5.49%	6,150 $110,000
Q3 2020 Oct 06, 2020	BUY	$11.55 - $23.75 $727 - $1,496	63 Added 1.09%	5,830 $67,000
Q2 2020 Jul 10, 2020	BUY	$9.57 - $24.37 $277 - $706	29 Added 0.51%	5,767 $139,000
Q1 2020 Apr 17, 2020	BUY	$9.07 - $26.32 $52,043 - $151,024	5,738 New	5,738 $63,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.